Jasmine McCarthy is the National Awareness Director for Drugwatch.com. She contacted me with this important information on Actos and Type 2 diabetes, and asked if I’d like it for a guest post. I said, “Absolutely,” and here it is.
Dangerous Actos Complications for Type 2 Diabetes
Actos has become a bestselling drug among people with type 2 diabetes. The pill has the ability to lower blood sugar by sensitizing the body’s cells to insulin. Its effectiveness has prompted more than 10 million people with type 2 to fill Actos prescriptions around the world.
Somehow the popularity of Actos has yet to wane, even though many studies show it causes terrible side effects. These complications can range from cancer to an increased risk of broken bones. If a friend of yours is taking Actos please make sure they’re aware of its dangers.
Studies now show that Actos increases the risk of bladder cancer by 88 percent
when patients take it more than two years. Using it for one year has been associated with a 40 percent increased risk. Some scientists believe that Actos releases microcrystals into people’s bladders that eventually cause cancer. Because cancer in Actos users takes a long time to develop this side effect was only discovered in 2010.
Congestive Heart Failure
Since 2007 Actos has carried the Food and Drug Administration’s strongest warning label. It’s called the black-box. The label is only used when drugs may injure or kill patients. Actos has a black-box for increasing the risk of congestive heart failure. Users are 30 percent more likely to have a heart attack when taking Actos.
Actos can triple the risk of users getting an eye disorder called macular edema. This condition can cause blurred vision and distorted color perception. In severe cases it can even cause blindness.
Women in their late 40s and early 50s are already vulnerable to fractures because menopause reduces their bone strength. When women in this age group take Actos, the drug can weaken their bones further, making them more at risk of injury. Studies show Actos doubles the normal risk of women fracturing bones at this age.
As you can see Actos comes with a lot of complications. It’s a wonder some doctors are still recommending it. Researchers are continuing to gather evidence about the drug’s side effects. One major study on Actos’ bladder cancer risk will publish its results in 2013. With any luck, its finding will be enough to convince the FDA that Actos is just too dangerous to keep on the market. People affected by Actos are not waiting for the results of these studies. Many have decided to take actions into their own hands by filing an Actos lawsuit.
William Richards researches and writes about prescription drugs and medical devices for Drugwatch.com.